Sesquiterpenoid analogs
US11814396B2 · kind B2 · utility
0Cited by
0References
2Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 3, 2021 |
| Grant date | Nov 14, 2023 |
| Priority date | — |
| Expiry date | Oct 4, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D493/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present disclosure relates to novel sesquiterpenoid compounds as SHP2 and/or POLE3 inhibitors for potential treatment for cancers, and to methods of making and using the sesquiterpenoid compounds. The present invention therefore provides a method of using the disclosed compounds as chemosensitizations agent to a DNA damaging drugs for cancers.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.